Ying Huang
Senior Reporter, APAC, Pharma insights
+14 year(s) experience
Prior to joining Informa, Ying was the China Bureau Editor of BioPharm Insight, a Financial Times Group product. She led the investigative coverage on the important situations taking place within the healthcare industry, delivering breaking news and insights on the biopharmaceutical industry in China and Southeast Asia.
Ying has covered academic and industry meetings in China and Asia where she has interviewed C-level executives and key opinion leaders. She has also worked as an international business development assistant at a China-listed pharmaceutical company.
Ying holds a Master's degree in Public Health from the University of Westminster in London, and a bachelor’s degree in biotechnology.
Scrip
Chinese start-up CARsgen Therapeutics hopes to launch trials in the US for its first-in-class anti-claudin18.2 CAR-T cell therapy.
Topic Clinical trials
Scrip
13 Feb 2018
Scrip
19 Dec 2017
Scrip
08 Dec 2017
Scrip
19 Sep 2017
Scrip
01 Sep 2017
Scrip
30 Aug 2017
Scrip
23 Aug 2017
Scrip
10 Aug 2017
Pink Sheet
20 Jul 2017
Scrip
12 Jul 2017
Scrip
16 Jun 2017
Scrip
14 Jun 2017
Scrip
08 Jun 2017
Scrip
07 Jun 2017
Scrip
16 May 2017